Choroid plexus, ageing of the brain, and Alzheimer's disease

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Serot, Jean Marie ^a,b,c   Béné, Marie Christine ^b   Faure, Gilbert C ^b  

^a Hotel Dieu   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Laboratoire d'Immunologie   (France)

Author keywords

Aging; Alzheimer's disease; Cerebrospinal fluid; Choroid Plexus; Review

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN; BRAIN PROTECTION; CEREBROSPINAL FLUID; CHOROID PLEXUS; ENZYME MODIFICATION; EPENDYMA CELL; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METHYLATION; REVIEW; SENESCENCE; AGING; ANIMAL; HUMAN; PATHOLOGY; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CHOROID PLEXUS; HUMANS;

EID: 1542778656     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Selkoe D. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 S, A23-A31 (1999)
2. Mirra S.S., A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle & L. Berg. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486 (1991)
3. Davies P. A very incomplete comprehensive theory of Alzheimer's disease. Ann NY Acad Sci 924, 8-16 (2000)
4. Kuo Y.M., M.R. Emmerling, C. Vigo-Pelfrey, T.C. Kasunic, J.B. Kirkpatrick, G.H. Murdoch, M.J. Ball & A.E. Roher. Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271, 4077-4081 (1996)
5. Lovell M.A., S.P. Gabbita & W.R. Markesbery. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 72, 771-776 (1999)
6. Smith M.A., L.M. Sayre, V.M. Monnier & G. Perry. Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles. Mol Chem Neuropath 28, 41-48 (1996)
7. Katzman R. Alzheimer's disease as an age-dependent disorder. Ciba Foundation Symposium 134, 69-85 (1988)
8. Soto C., G.P. Saborio & B. Permanne. Inhibiting the conversion of soluble amyloid-β peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy. Acta Neurol Scand S176, 90-95 (2000)
9. Johanson C.E. Ventricles and cerebrospinal fluid. In: Neuroscience in Medicine. Eds : Conn P.M., Lippincott J.B., Philadelphia, 171-196 (1995)
10. Zheng W. Choroid plexus and metal toxicity. In: Toxicology of metals. Eds: Chang L.W., CRC Lewis Publishers, London, 609-626 (1996)
11. Dohrmann G.J. The choroid plexus: a historical review. Brain Res 18, 197-218 (1970)
12. Cornford E.M., J.B. Varesi, S. Hyman, R.T. Damian & M.J. Raleigh. Mitochondrial content of choroid plexus epithelium. Exp Brain Res 116, 399-405 (1997)
13. Dohrmann G.J. Dark and light epithelial cells in the choroid plexus of mammals. J Ultrastruct Res 32, 268-273 (1970)
14. Serot J.M., M.C. Béné, B. Foliguet & G.C. Faure. Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium. J Neuroimmunol 105, 115-119 (2000)
15. Nilsson C., R. Ekman, M. Lindvall-Axelsson & C. Owman. Distribution of peptidergic nerves in the choroid plexus, focusing on coexistence of neuropeptide Y, vasoactive intestinal polypeptide and peptide histidine isoleucine. Regul Pept 27, 11-26 (1990)
16. Faraci F.M., W.G. Mayhan & D.D. Heistad. Effect of serotonin on blood flow to the choroid plexus. Brain Res 478, 121-126 (1989)
17. Vannucci S.J., R.R. Clark, E. Koehler-Stec, K. Li, C.B. Smith, P. Davies, F. Maher & I.A. Simpson. Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 20, 369-379 (1998)
18. Kim K.S., J. Wegiel, V. Sapienza, J. Chen, H. Hong & H.M. Wisniewski. Immunoreactivity of presenilin-1 in human, rat, and mouse brain. Brain Res 757, 159-163 (1997)
19. Johnson M.D., J.M. Kamso-Pratt, W.O.Jr Whetsell & R.B. Pepinsky. Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol 92, 424-429 (1989)
20. Gander R., P. Eller, S. Kaser, I. Theurl, D. Sauper, A. Ritsch, J.R. Patsch & B. Foger. Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein. J Lipid Res 43, 636-645 (2002)
21. Aldred A.R., C.M. Brack & G. Schreiber. The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol 111B: 1-15 (1995)
22. Stopa E.G., T. M. Berzin, S. Kim, P. Song, V. Kuo-Leblanc, M. Rodriguez-Wolf, A. Baird & C.E. Johanson. Human choroid plexus growth factors: what are the implications for CSF dynamics in Alzheimer's disease. Exp Neurol 167, 40-47 (2001)
23. Spector R. Vitamin homeostasis in the central nervous system. New Eng J Med 296, 1393-1398 (1977)
24. Fand I. & W.P. McNally. Whole-body localization of 14C-tocopherylacetate in the rat following oral administration. Arch Int Pharmacodyn Ther 250, 4-17 (1981)
25. Ghersi-Egea J.F., B. Leininger-Muller, G. Suleman, G. Siest & A. Minn. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62, 1089-1096 (1994)
26. Stoll J., K.C. Wadhwani & Q.R. Smith. Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier. J Neurochem 60, 1956-1959 (1993)
27. Gao B., P.J. Meier. Organic anion transport across the choroid plexus. Microsc Res Tech 52, 60-64 (2001)
28. Dwyer K.J. & W.M. Pardridge. Developmental modulation of blood-brain barrier and choroid plexus GLUT1 glucose transporter messenger ribonucleic acid and immunoreactive protein in rabbits. Endocrinology 132, 558-565 (1993)
29. Segal M.B. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol 20, 183-196 (2000)
30. Felgenhauer K. The blood-brain barrier redefined. J Neurol 233, 193-194 (1986)
31. Weisner B. & H.J. Roethig. The concentration of prealbumin in cerebrospinal fluid (CSF), indicator of CSF circulation disorders. Eur Neurol 22, 96-105 (1983)
32. 125I-labelled β-amyloid transport in the aged sheep isolated perfused choroid plexus. J Physiol 515P, 7-8P (1999)
33. Serot J.M., MC. Béné, B. Foliguet & G.C. Faure. Choroid plexus and ageing: a morphometric and ultrastructural study. Eur J Neurosci 14, 794-798 (2001)
34. Sturrock R.R. An ultrastructural study of the choroid plexus of aged mice. Anat Anz 165, 379-385 (1988)
35. Serot J.M., M.C. Béné, B. Foliguet & G.C. Faure. Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathol 99, 105-108 (2000)
36. Wen G.Y., H.M. Wisniewski & R.J. Kascsak. Biondi ring tangles in the choroid plexus of Alzheimer's disease and normal aging brains: a quantitative study. Brain Res 832, 40-46 (1999)
37. Shuangshoti S. & M.G. Netsky. Human choroid plexus: morphologic and histochemical alterations with age. Am J Anat 128, 73-96 (1970)
38. Ferrante F. & F. Amenta. Enzyme histochemistry of the choroid plexus in old rats. Mech Ageing Dev 41, 65-72 (1987)
39. Cottrell D.A., E.L. Blakely, M.A. Johnson, P.G. Ince, G.M. Borthwick & D.M. Turnbull. Cytochrome oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol. Aging 22, 265-272 (2001)
40. Kvitnitskaia-Ryzhova T.I. & A.L. Shkapenko. A comparative ultracytochemical and biochemical study of the ATPases of the choroid plexus in aging. Tsitologiia 34, 81-87 (1992)
41. Preston J.E. Age-related reduction in rat choroid plexus chloride efflux and CSF secretion rate. Soc Neurosci 25, P697-698 (1999)
42. Preston J.E. Ageing choroid plexus-cerebrospinal fluid system. Microsc Res Tech 52, 31-37 (2001)
43. May C., J.A. Kaye, J.R. Atack, M.B. Schapiro, R.P. Friedland & S.I. Rapoport. Cerebrospinal fluid production is reduced in healthy aging. Neurology 40, 500-503 (1990)
44. Tanna N.K., M.I. Kohn, D.M. Norwich, P.R. Jolles, R.A. Zimmerman, W.M. Alves & A. Alavi. Analysis of brain and cerebrospinal fluid volumes with MR Imaging: Impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology 178, 123-130 (1991)
45. Albeck M.J., C. Skak, P.R. Nielsen, K.S. Olsen, S.E. BØrgesen & F. Gjerris. Age dependency of resistance to cerebrospinal fluid outflow. J Neurosurg 89, 275-278 (1998)
46. Kunicki S., J. Richardson, P.D. Mehta, K.S. Kim & E. Zorychta. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-β (Aβ) 40, A β42, apolipoprotein E and transthyretin in human cerebrospinal fluid. Clin Biochem 31, 409-415 (1998)
47. Serot J.M., D. Christmann, T. Dubost & M. Couturier. Cerebrospinal fluid transthyretin: aging and late onset alzheimer's disease. J Neurol Neurosurg Psychiatry 63, 506-508 (1997)
48. Zheng W. Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc Res Tech 52, 89-103 (2001)
49. Goebel H.H. & J. Muller. Ultrastructural observations on silver deposition in the choroid plexus of a patient with argyria. Acta Neuropathol 26, 247-251 (1973)
50. Kira R., S. Ohga, H. Takada, K. Gondo, F. Mihara & T. Hara. MR choroid plexus sign of iron overload. Neurology 55, 1340 (2000)
51. Parnetti L., Reboidi G.P. & V. Gallai. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology 54, 735-737 (2000)
52. Miklossy J., R. Kraftsik, O. Pillevuit, D. Lepori, C. Genton & F.T. Bosman. Curly fiber and tangle-like inclusions in the ependyma and choroid plexus - a pathogenetic relationship with the cortical Alzheimer-type changes? J Neuropathol Exp Neurol 57, 1202-1212 (1998)
53. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 76, 83-102 (1976)
54. Serot J.M., M.C. Béné & G.C. Faure. Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer's dementia. Hum Pathol 25, 1185-1190 (1994)
55. Coblentz J.M., S. Mattis, L.H. Zingesser, S.S. Kasoff, H.M. Wisniewski & R. Katzman. Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol 29, 299-308 (1973)
56. Serot J.M., A. Bertrand, F. Penin, C. Hocquard, M.C. Mietkiewicz & G. Cuny. La cysternographie isotopique dans les détériorations mentales et les démences du sujet âgé. Med Hyg 36, 1928-1930 (1978)
57. Brusa G., F. Claudiani, A. Piccardo, N. Pizioo & R. Stoehr. Scinticisternography in presenile and senile degenerative disease. Ital J Neurol Sci 11, 43-47 (1990)
58. Silverberg G.D., G. Heit, S. Huhn, R.A. Jaffe, S.D. Chang, H. Bronte-Stewart, E. Rubenstein, K. Possin & T.A. Saul. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 57, 1763-1766 (2001)
59. Atack J.R., S.I. Rapoport & M.B. Schapiro. Cerebrospinal fluid production is normal in Down syndrome. Neurobiol Aging 19, 307-309 (1998)
60. Vitek M.P., K. Battacharaya, J.M. Glendening, E. Stopa, H. Vlassara, R. Bucala, K. Manogue & A. Cerami. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91, 4766-4770 (1994)
61. Troncoso J.C., A. Costello, A.L. Watson Jr & G.V.W. Johnson. In vitro polymerization of oxidized tau into filaments. Brain Res 613, 313-316 (1993)
62. Munch G., R. Schinzel, C. Loske, A. Wong, N. Durany, J.J. Li, H. Vlassara, M.A. Smith, G. Perry & P. Riederer. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105, 439-461 (1998)
63. Shuvaev V.V., I. Laffont, J.M. Serot, J. Fujii, N. Taniguchi & G. Siest. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease patients. Neurobiol Aging 22, 397-402 (2001)
64. Klein W.L., G.A. Krafft & C.E. Finch. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24, 219-224 (2001)
65. Walsh D.M., I. Klyubin, J.V. Fadeeva, M.J. Rowan & D.J. Selkoe. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30, 552-557 (2002)
66. Johanson C.E., J. Szmydynger-Chodobska J, A. Chodobski, A. Baird, P. McMillan & E.G. Stopa. Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus. Am J Physiol 277, R263-R271 (1999)
67. Bellur S.N, V. Chandra & L.W. McDonald. Arachnoid cell hyperplasia. Its relationship to aging and chronic renal failure. Arch Pathol Lab Med 104, 414-416 (1980)
68. Schwarzman A.L. & D. Goldgaber. Interaction of transthyretin with amyloid β-protein: binding and inhibition of amyloid formation. Ciba Foundation Symposium 199, 146-164 (1996)
69. Tsuzuki K., R. Fukatsu, H. Yamaguchi, M. Tateno, K. Imai, N. Fujii & T. Yamauchi. Transthyretin binds amyloid beta peptides, Abeta1-42 and Abeta1-40 to form complex in the autopsied human kidney-possible role of transthyretin for Abeta sequestration. Neurosci Lett 281, 171-174 (2000)
70. Riisoen H. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease. Acta Neurol Scand 78, 455-459 (1988)
71. Dorta-Contreras A.J., M. Barshatzky, E. Noris-Garcia & T. Serrano-Sánchez. Niveles de transtirretina en suero y en liquido cefalorraquideo apoyan la hipótesis nutrio-virica de la neuropatia epidémica cubana. Rev Neurol 31, 801-804 (2000)
72. Ikeda T., Y. Furukawa, S. Mashimoto, K. Takahashi & M. Yamada. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr Scand 82, 327-329 (1990)
73. Serot J.M., D. Christmann, T. Dubost, M.C. Béné & G.C. Faure. CSF-folate levels are decreased in late-onset AD patients. J Neural Transm 108, 93-99 (2001)
74. Selley M.L., D.R. Close & S.E. Stern. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging 232, 383-388 (2002)
75. Tohgi H., T. Abe, M. Nakanishi, F. Hamato, K. Sasaki & S. Takahashi. Concentrations of □-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci Lett 174, 73-76 (1994)
76. Schippling S., A. Kontush, S. Arlt, C. Buhmann, H.J. Stürenburg, U. Mann, T. Müller-Thomsen & U. Beisiegel. Increased lipoprotein oxidation in Alzheimer's disease. Free Rad Biol Med 28, 351-360 (2000)
77. De La Torre J.C. Impaired cerebromicrovascular perfusion: summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 924, 136-152 (2000)
78. Rubenstein E. Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged. Lancet 351, 283-285 (1998)